Christof Rottenburger

ORCID

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Venues

EJNMMI research

Diagnostics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Christof Rottenburger, Michael Hentschel, Markus Fürstner, Lisa McDougall, Danijela Kottoros, Felix Kaul, Rosalba Mansi, Melpomeni Fani, A Hans Vija, Roger Schibli, Susanne Geistlich, Martin Behe, Emanuel R Christ, Damian Wild
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI research 14 (1) (2024)
Christof Rottenburger, Michael Hentschel, Markus Fürstner, Lisa McDougall, Danijela Kottoros, Felix Kaul, Rosalba Mansi, Melpomeni Fani, A Hans Vija, Roger Schibli, Susanne Geistlich, Martin Behe, Emanuel R Christ, Damian Wild
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI research 14 (1) (2024)
Christof Rottenburger, Michael Hentschel, Markus Fürstner, Lisa McDougall, Danijela Kottoros, Felix Kaul, Rosalba Mansi, Melpomeni Fani, A Hans Vija, Roger Schibli, Susanne Geistlich, Martin Behe, Emanuel R Christ, Damian Wild
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI research 14 (1) (2024)
Andrea K Hemmig, Christof Rottenburger, Markus Aschwanden, Christoph T Berger, Diego Kyburz, Maurice Pradella, Daniel Staub, Stephan Imfeld, Gregor Sommer, Thomas Daikeler
Magnetic Resonance Imaging Findings Corresponding to Vasculitis as Defined via [ 18 F]FDG Positron Emission Tomography or Ultrasound. Diagnostics (Basel, Switzerland) 13 (23) (2023)

Christof Rottenburger.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christof Rottenburger